DYN logo

Dyne Therapeutics (DYN) Accounts payable

annual accounts payable:

$6.56M-$16.37M(-71.39%)
December 31, 2024

Summary

  • As of today (May 29, 2025), DYN annual accounts payable is $6.56 million, with the most recent change of -$16.37 million (-71.39%) on December 31, 2024.
  • During the last 3 years, DYN annual accounts payable has risen by +$2.53 million (+62.79%).
  • DYN annual accounts payable is now -71.39% below its all-time high of $22.94 million, reached on December 31, 2023.

Performance

DYN Accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

quarterly accounts payable:

$7.02M+$457.00K(+6.96%)
March 31, 2025

Summary

  • As of today (May 29, 2025), DYN quarterly accounts payable is $7.02 million, with the most recent change of +$457.00 thousand (+6.96%) on March 31, 2025.
  • Over the past year, DYN quarterly accounts payable has dropped by -$195.00 thousand (-2.70%).
  • DYN quarterly accounts payable is now -69.40% below its all-time high of $22.94 million, reached on December 31, 2023.

Performance

DYN quarterly accounts payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDYNbalance sheet metrics

Accounts payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

DYN Accounts payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-71.4%-2.7%
3 y3 years+62.8%+35.3%
5 y5 years+422.4%-

DYN Accounts payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-71.4%+62.8%-69.4%+663.8%
5 y5-year-71.4%+422.4%-69.4%+663.8%
alltimeall time-71.4%+1166.8%-69.4%+663.8%

DYN Accounts payable History

DateAnnualQuarterly
Mar 2025
-
$7.02M(+7.0%)
Dec 2024
$6.56M(-71.4%)
$6.56M(+6.6%)
Sep 2024
-
$6.16M(+225.9%)
Jun 2024
-
$1.89M(-73.8%)
Mar 2024
-
$7.21M(-68.5%)
Dec 2023
$22.94M(+336.1%)
$22.94M(+545.5%)
Sep 2023
-
$3.55M(+30.4%)
Jun 2023
-
$2.72M(-68.9%)
Mar 2023
-
$8.77M(+66.8%)
Dec 2022
$5.26M
$5.26M(+472.3%)
Sep 2022
-
$919.00K(-86.8%)
DateAnnualQuarterly
Jun 2022
-
$6.97M(+34.4%)
Mar 2022
-
$5.19M(+28.7%)
Dec 2021
$4.03M(+17.2%)
$4.03M(-43.1%)
Sep 2021
-
$7.09M(+25.5%)
Jun 2021
-
$5.65M(-1.9%)
Mar 2021
-
$5.76M(+67.4%)
Dec 2020
$3.44M(+173.9%)
$3.44M(+131.2%)
Sep 2020
-
$1.49M(-32.1%)
Jun 2020
-
$2.19M(+74.5%)
Dec 2019
$1.26M(+142.5%)
$1.26M
Dec 2018
$518.00K
-

FAQ

  • What is Dyne Therapeutics annual accounts payable?
  • What is the all time high annual accounts payable for Dyne Therapeutics?
  • What is Dyne Therapeutics annual accounts payable year-on-year change?
  • What is Dyne Therapeutics quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Dyne Therapeutics?
  • What is Dyne Therapeutics quarterly accounts payable year-on-year change?

What is Dyne Therapeutics annual accounts payable?

The current annual accounts payable of DYN is $6.56M

What is the all time high annual accounts payable for Dyne Therapeutics?

Dyne Therapeutics all-time high annual accounts payable is $22.94M

What is Dyne Therapeutics annual accounts payable year-on-year change?

Over the past year, DYN annual accounts payable has changed by -$16.37M (-71.39%)

What is Dyne Therapeutics quarterly accounts payable?

The current quarterly accounts payable of DYN is $7.02M

What is the all time high quarterly accounts payable for Dyne Therapeutics?

Dyne Therapeutics all-time high quarterly accounts payable is $22.94M

What is Dyne Therapeutics quarterly accounts payable year-on-year change?

Over the past year, DYN quarterly accounts payable has changed by -$195.00K (-2.70%)
On this page